Cefepime and the inoculum effect in tests with Klebsiella pneumoniae producing plasmid-mediated AmpC-type β-lactamase | Zendy

CheolIn Kang | Zendy; Hyunjoo Pai | Zendy; SungHan Kim | Zendy; Hong Bin Kim | Zendy; Eui-Chong Kim | Zendy; Myoungdon Oh | Zendy; Kang Won Choe | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Cefepime and the inoculum effect in tests with Klebsiella pneumoniae producing plasmid-mediated AmpC-type β-lactamase

Author(s) -

CheolIn Kang,

Hyunjoo Pai,

SungHan Kim,

Hong Bin Kim,

Eui-Chong Kim,

Myoungdon Oh,

Kang Won Choe

Publication year - 2004

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkh462

Subject(s) - cefepime , klebsiella pneumoniae , microbiology and biotechnology , plasmid , klebsiella , biology , enterobacteriaceae , cephalosporin , antibiotics , antibiotic resistance , escherichia coli , imipenem , gene , genetics

In the past decade, a new problem in Klebsiella pneumoniae strains has emerged: plasmid-mediated AmpC enzymes. This study was conducted to investigate the activity of cefepime against clinical isolates by determining the activities of cefepime and three other parenteral beta-lactam agents in standard and high inoculum MIC tests.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research